NFE2 and neoplasm: Estradiol has been proposed as a protective factor, as it modulates inflammation by increasing the expression of Nrf2 (nuclear factor erythroid 2) [12], downregulates PD-L1 (programmed death-ligand 1), potentially altering the immunosuppressive tumor microenvironment, and favorably influences microbiota composition [22].